Synlogic, Inc.

Synlogic, Inc.

Synlogic, Inc.

Overview
Date Founded

2017

Headquarters

301 Binney Street,Suite 402,Cambridge, MA 02142

Type of Company

Public

Employees (Worldwide)

76

Industries

Biotechnology

Company Description

Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.

Executives & Employees

Co-Founder

Co-Founder

President, Chief Executive Officer & Director

Chief Financial & Accounting Officer

Chief Scientific Officer

Chief Human Resources Officer

Chief Medical Officer

Head-Regulatory Affairs

Head of Investor Relations & Corporate Communications

Paths to Synlogic, Inc.
Potential Connections via
Relationship Science
You
Synlogic, Inc.
Recent Transactions
Details Hidden

Synlogic, Inc. issued USD Common Stock

Transaction Advisors
Escrow Agent

Advised onSynlogic, Inc. issued USD Common Stock

Underwriter

Advised onSynlogic, Inc. issued USD Common Stock

Legal Advisor

Advised onSynlogic, Inc. issued USD Common Stock

Professional

Advised onSynlogic, Inc. issued USD Common Stock

Professional

Advised onSynlogic, Inc. issued USD Common Stock

Legal Advisor

Advised onSynlogic, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Chief Scientific Officer at Artizan Biosciences, Inc.

Advisor

Global Head of Drug Discovery at AbbVie, Inc.

Advisor

Director & Chief Scientist at Kalion, Inc.

Clients

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Key Stats and Financials As of 2019
Market Capitalization
$79.8M
Total Enterprise Value
$-16.4M
Earnings Per Share
$-1.7
Revenue
$2.22M
Net Profit
$-51.4M
EBITDA
$-50.3M
EBITDAMargin
-2,263.35%
Total Debt
$25M
Total Equity
$157M
Enterprise Value Sales
-7.38x
TEVNet Income
0.32x
Debt TEV
-1.52x
Suppliers
Rosetta Genomics Ltd. Medical Products & Equipment | Rehovot, Israel

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Massachusetts Institute of Technology Hospitals & Patient Services | Cambridge, MA

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Roche Holding AG Medical Support Services | Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Agios Pharmaceuticals, Inc. Pharmaceuticals - Cambridge, Massachusetts

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Synlogic, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Synlogic, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Synlogic, Inc..